FindTrial
Sign In

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for colorectal cancer screening: pilot and feasibility study

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for colorectal cancer screening: pilot and feasibility study - DWIBS for colorectal cancer screening: pilot and feasibility study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31707
Enrollment
40
Registered
2008-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer Colorectal cancer

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients with an endoscopically unremovable colorectal tumor, and patients who have undergone a colonoscopy and who do not have a colorectal tumor, in the UMC Utrecht -Age: 18 years and older -Written informed consent

Exclusion criteria

Exclusion criteria: -Patients with a general contraindication for MRI (including cardiovascular pacemakers, claustrophobia) -Patients who have had a previous malignancy -Patients who are pregnant or nursing -Patients in whom therapy has already started

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of DWIBS (with 95% confidence intervals) for the detection of tumors (carcinoma/polyp).—

Secondary

MeasureTime frame
N.A.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)